User profiles for A Casadevall
Arturo CasadevallJohns Hopkins School of Public Health Verified email at jhu.edu Cited by 93352 |
[HTML][HTML] Deployment of convalescent plasma for the prevention and treatment of COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2), the cause of coronavirus
disease 2019 (COVID-19), has spurred a global health crisis. To date, there are no proven …
disease 2019 (COVID-19), has spurred a global health crisis. To date, there are no proven …
[HTML][HTML] Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity
A Casadevall, L Pirofski - Infection and immunity, 1999 - Am Soc Microbiol
While preparing to teach the Microbial Pathogenesis graduate course at our institution, we
found ourselves struggling to find basic definitions of virulence and pathogenicity that …
found ourselves struggling to find basic definitions of virulence and pathogenicity that …
[HTML][HTML] Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi
…, JM Wolf, R Prados-Rosales, A Casadevall - Nature Reviews …, 2015 - nature.com
Extracellular vesicles (EVs) are produced by all domains of life. In Gram-negative bacteria,
EVs are produced by the pinching off of the outer membrane; however, how EVs escape the …
EVs are produced by the pinching off of the outer membrane; however, how EVs escape the …
Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients
…, NS Paneth, NC Verdun, P Marks, A Casadevall… - Mayo Clinic …, 2020 - Elsevier
Objective To provide an update on key safety metrics after transfusion of convalescent plasma
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …
[HTML][HTML] Early outpatient treatment for Covid-19 with convalescent plasma
Background Polyclonal convalescent plasma may be obtained from donors who have
recovered from coronavirus disease 2019 (Covid-19). The efficacy of this plasma in preventing …
recovered from coronavirus disease 2019 (Covid-19). The efficacy of this plasma in preventing …
[HTML][HTML] The convalescent sera option for containing COVID-19
A Casadevall, L Pirofski - The Journal of clinical …, 2020 - Am Soc Clin Investig
As of early 2020, humanity is confronting a pandemic in severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). SARS-CoV-2 causes coronavirus disease, abbreviated as …
coronavirus 2 (SARS-CoV-2). SARS-CoV-2 causes coronavirus disease, abbreviated as …
Misconduct accounts for the majority of retracted scientific publications
…, RG Steen, A Casadevall - Proceedings of the …, 2012 - National Acad Sciences
A detailed review of all 2,047 biomedical and life-science research articles indexed by PubMed
as retracted on May 3, 2012 revealed that only 21.3% of retractions were attributable to …
as retracted on May 3, 2012 revealed that only 21.3% of retractions were attributable to …
[HTML][HTML] Early safety indicators of COVID-19 convalescent plasma in 5000 patients
…, NC Verdun, P Marks, A Casadevall - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Convalescent plasma is the only antibody-based therapy currently available
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …
[BOOK][B] Cryptococcus neoformans
A Casadevall, JR Perfect - 1998 - Citeseer
MATERIALS AND METHODS Strains and media. C. neoformans var. grubii strains H99 (70),
KN99a (55), KN99 (55), KN99aNAT, and KN99NAT were maintained at 80 C. Cultures were …
KN99a (55), KN99 (55), KN99aNAT, and KN99NAT were maintained at 80 C. Cultures were …
Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages
…, HA Shuman, A Casadevall - Proceedings of the …, 2001 - National Acad Sciences
Cryptococcus neoformans (Cn) is a soil fungus that causes life-threatening meningitis in
immunocompromised patients and is a facultative intracellular pathogen capable of replication …
immunocompromised patients and is a facultative intracellular pathogen capable of replication …